Literature DB >> 16007400

D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease.

Isao Sakaida1, Kotaro Kawaguchi, Teruaki Kimura, Fusako Tamura, Kiwamu Okita.   

Abstract

We report a 13-year-old girl who presented with hepatic failure and hemolytic anemia. Laboratory findings showed a normal serum copper level (104 microg/dl), high urinary copper level (2370 microg/dl), and low serum ceruloplasmin level (14.3 microg/dl). Slit-lamp examination revealed Kayser-Fleischer rings on her cornea, and she was diagnosed with Wilson's disease. Plasma exchange and continuous hemodiafiltration relieved the serious condition, after that laparoscopic examination was performed. Administration of D-penicillamine and restriction of dietary copper (<1 mg/day) were started, leading to a normalized serum alanine amino transferase (ALT) level. After 3 years, she again underwent laparoscopic examination, and the laparoscopic and histological findings of her liver were obviously improved. Management of the copper level can reverse severe liver fibrosis in Wilson's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007400     DOI: 10.1007/s00535-005-1600-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

1.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

2.  Plasma exchange for fulminant Wilson disease.

Authors:  J Sarles; P Lefevre; G Picon
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

3.  Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.

Authors:  A Czlonkowska; J Gajda; M Rodo
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

4.  Orthotopic liver transplantation for acute fulminant Wilson disease.

Authors:  R J Sokol; P D Francis; S H Gold; D M Ford; G M Lum; D R Ambruso
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

5.  Long-term therapy of Wilson's disease.

Authors:  A Deiss; R E Lynch; G R Lee; G E Cartwright
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

6.  Mapping, cloning and genetic characterization of the region containing the Wilson disease gene.

Authors:  K Petrukhin; S G Fischer; M Pirastu; R E Tanzi; I Chernov; M Devoto; L M Brzustowicz; E Cayanis; E Vitale; J J Russo
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

7.  Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509.

Authors:  Alastair Compston
Journal:  Brain       Date:  2009-08       Impact factor: 13.501

8.  Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.

Authors:  Y Yamaguchi; M E Heiny; J D Gitlin
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

9.  Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).

Authors:  T Dahlman; P Hartvig; M Löfholm; H Nordlinder; L Lööf; K Westermark
Journal:  QJM       Date:  1995-09

10.  Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Authors:  George J Brewer; Peter Hedera; Karen J Kluin; Martha Carlson; Fred Askari; Robert B Dick; Julia Sitterly; John K Fink
Journal:  Arch Neurol       Date:  2003-03
View more
  1 in total

1.  Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: earlier administration of chelating therapy can reduce the damage to the brain.

Authors:  Duško B Kozić; Igor Petrović; Marina Svetel; Tatjana Pekmezović; Aleksandar Ragaji; Vladimir S Kostić
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.